EZH2 and non-Hodgkin lymphoma: Furthermore, high EZH2 protein expression was associated with inferior PFS rates (T-NHL: median PFS 29.0 vs. 9.0 months; p = 0.016; nodal T-NHL: median PFS 22.0 vs. 9.0 months; p = 0.042).